Cut losses. This stock is not done pulling back imo.
If the company was well funded I'd say hold but this is not promising in the least. I would take advantage of NWBO and AGEN pullbacks if looking to invest in GBM. Forget Delmar though. No need for toxic therapies anymore.
It sure looks like it. Since the therapy is only good for HLA patients that means that only one of their six peptides will be of any significance in the therapy anymore. That peptide is already present in NWBO's therapy so IMUC is in quite of a bad position IMO. I would recommend cutting losses and investing elsewhere. A lot of bargains out there right now.